home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Zoetis (NY:ZTS)

120.08 UNCHANGED

Streaming Delayed Price Updated: 7:00 PM EDT, Apr 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Zoetis

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

24 25 Next >

Zoetis Q3 Earnings Beat, Companion Animal Segment Growth Gives Confidence Into 2025: Analyst ↗

November 04, 2024

Zoetis Inc's Q3 2024 results show a 16% EPS increase and an 11% revenue boost. The company raises its 2024 guidance, highlighting strong global growth in key segments.

Via Benzinga

Topics Earnings

Zoetis (ZTS) Q3 2024 Earnings Call Transcript ↗

November 04, 2024

ZTS earnings call for the period ending September 30, 2024.

Via The Motley Fool

Topics Earnings

Zoetis Barks Up A Third-Quarter Beat And Raise, But Stock Slips ↗

November 04, 2024

Zoetis stock inched higher Monday after the animal health company beat third-quarter expectations and raised its outlook.

Via Investor's Business Daily

Zoetis Announces Third Quarter 2024 Results

November 04, 2024

From Zoetis Inc.

Via Business Wire

'Venture Investing Is Random,' Says Kevin O'Leary. The Craziest Bets, Like Cat DNA Tests, Often Cover All The Losses ↗

October 31, 2024

Via Benzinga

Here's How Much $1000 Invested In Zoetis 10 Years Ago Would Be Worth Today ↗

October 14, 2024

Via Benzinga

In-Depth Examination Of 7 Analyst Recommendations For Zoetis ↗

October 11, 2024

Via Benzinga

$1000 Invested In Zoetis 10 Years Ago Would Be Worth This Much Today ↗

September 30, 2024

Via Benzinga

Zoetis Declares Fourth Quarter 2024 Dividend

October 10, 2024

From Zoetis Inc.

Via Business Wire

10 Health Care Stocks Whale Activity In Today's Session ↗

October 07, 2024

Via Benzinga

Zoetis and Danone Announce Strategic Partnership to Pioneer Sustainable Innovation in Dairy Farming Using the Power of Genetics

September 26, 2024

From Zoetis Inc.

Via Business Wire

Where Zoetis Stands With Analysts ↗

September 18, 2024

Via Benzinga

Here's How Much You Would Have Made Owning Zoetis Stock In The Last 10 Years ↗

September 05, 2024

Via Benzinga

Here's How Much $100 Invested In Zoetis 10 Years Ago Would Be Worth Today ↗

August 23, 2024

Via Benzinga

How Is The Market Feeling About Zoetis? ↗

August 16, 2024

Via Benzinga

Elanco's Dermatology Treatment Secures FDA Approval For Itchy Dogs, Analyst Highlights Label Warnings And Efficacy ↗

September 20, 2024

FDA approves Elanco's once-daily oral treatment, Zenrelia, for controlling itching in dogs with allergic and atopic dermatitis. The drug, proven effective in studies, faces adoption challenges due to...

Via Benzinga

Zoetis to Host Webcast and Conference Call on Third Quarter 2024 Financial Results

September 19, 2024

From Zoetis Inc.

Via Business Wire

Starbucks To Rally More Than 22%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

September 18, 2024

Via Benzinga

Jim Cramer Says This Retailer Yields 3%: 'Which Is Quite Good' ↗

September 04, 2024

Jim Cramer discusses PROCEPT BioRobotics, Zoetis, Target and Consolidated Edison. "

Via Benzinga

The Latest Analyst Ratings For Zoetis ↗

August 14, 2024

Via Benzinga

Here's How Much $100 Invested In Zoetis 10 Years Ago Would Be Worth Today ↗

August 12, 2024

Via Benzinga

Why Zoetis Stock Was Moving Higher Tuesday ↗

August 06, 2024

It was a classic beat-and-raise quarter for Zoetis.

Via The Motley Fool

Zoetis to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

August 20, 2024

From Zoetis Inc.

Via Business Wire

Which Pet Stock Should Get Your Tail Wagging in 2024?

August 13, 2024

ZTS stock and CHWY stock have different investment cases, but here's what investors may want to consider before buying either of these pet stocks

Via MarketBeat

Topics Artificial Intelligence

Animal Health Firm Zoetis Clocks Strong Q2 Earnings, Companion Animal Operations Boost Confidence For 2024 ↗

August 06, 2024

Zoetis stock rises as Q2 revenue hits $2.36 billion, up 8% YOY, surpassing estimates. U.S. revenue grew 12%, driven by strong sales of companion animal products like Librela and Solensia. The company...

Via Benzinga

ZTS Stock Earnings: Zoetis Beats EPS, Beats Revenue for Q2 2024 ↗

August 06, 2024

ZTS stock results show that Zoetis beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

Zoetis Earnings Growth Picks Up, Tops Views ↗

August 06, 2024

The animal drug giant's EPS growth had decelerated in the prior two quarters.

Via Investor's Business Daily

Zoetis (ZTS) Q2 2024 Earnings Call Transcript ↗

August 06, 2024

ZTS earnings call for the period ending June 30, 2024.

Via The Motley Fool

Topics Earnings

Zoetis Announces Second Quarter 2024 Results

August 06, 2024

From Zoetis Inc.

Via Business Wire

Home Depot To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Monday ↗

August 05, 2024

Via Benzinga

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

24 25 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com